EuroPCR 2024 – from May 14th to 17th in Paris

The Latin American Society of Interventional Cardiology invites the entire community to participate in EuroPCR 2024, which will take place in Paris between the 14th and 17th of May 2024.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Invitation of the MIL Group to RISE at the ESC 2024 Congress

The Group of Latin American Interventional Women invites you to participate in the next RISE, a professional development conference for women in cardiology promoted...

Artificial Intelligence in Complex PCI Cases – 2nd International Symposium of Cardiology

The Latin American Society of Interventional Cardiology invites the whole community to take part in the 2nd International Symposium of Cardiology entitled “Artificial Intelligence...

SOLACI@PCR Joint Session at EuroPCR 2024 – See You in Paris on May 14 thru 17

The Latin American Society of Interventional Cardiology will once more say here at EuroPCR 2024, undoubtedly one of the most relevant international meetings in...

Cli-C Global 2024

The Latin American Society of Interventional Cardiology invites you to participate in Cli-C Global 2024, which will be held in Padua, Italy, between March...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....